Jayson M. Rieger
President, CEO & DirectorDr. Jayson M. Rieger, Ph.D., M.B.A., is President, CEO & Director of Verrica Pharmaceuticals Inc. from November 5, 2024. Dr. Rieger served as Non-Executive Independent Director at Lytix Biopharma AS since June 2021. He serves as Managing Partner at PBM Capital Group. He served as Principal at PBM Capital Group since 2014. He supports new investment evaluation, deal sourcing and provides technical and business support for portfolio companies. He has experience in cross-functional scientific and business leadership roles spanning business development, research operations, drug discovery and product development in the life sciences industry. Currently he supports the existing portfolio companies in the capacity of CDO of Baxis Pharmaceuticals and COO of Vetana. He served as Corporate Senior Vice President and President of Human Therapeutics Division at Intrexon Corporation from 2012 to 2013. Dr. Rieger served as the Vice President of Research and Virginia Operations, Vice President of Research and Vice President of Lead Development for Trovis Pharmaceuticals, a subsidiary of Clinical Data, Inc., from 2008 to 2011. He serves as Investment and Capital Market Advisor at Xalud Therapeutics, Inc. Dr. Rieger oversaw the Research Operations for the Early Development team and portfolio to Acting as the key business Manager and technical contact for several joint company relations. He served as the Vice President of Research and Virginia Operations for Forest Laboratories, Inc. He has also served as the Vice President of Research and Virginia Operations for Clinical Data, Inc. Dr. Rieger served as the Vice President of Lead Development & Manufacturing at Adenosine Therapeutics, LLC from 2002 to 2008. He serves as Board of Directors of Xalud Therapeutics, Inc, Baxis Pharmaceuticals, Vetana and Lytix Biopharma. Dr. Rieger has delivered several invited lectures at universities and scientific conferences. He is the co-author of more than 20 peer-reviewed publications and a co-inventor of more than 20 issued or pending patent applications. Dr. Rieger is a co-inventor or key team Member in multiple development programs ranging from discovery stage research to Phase III clinical trials. He was the recipient of more than 10 federal grants, serving as both Principal and co-investigator on efforts targeted towards evaluating adenosine receptor agents in a variety of disease indications. He is a co-inventor of more than 25 patents, has authorship on more than 25 peer reviewed scientific publications and was Principal/co-investigator on greater than 10 NIH grants. He served as Director of Verrica Pharmaceuticals Inc. from December 2015 to 2018. Dr. Rieger obtained his Ph.D. from the University of Virginia in Chemistry, an MBA from the Darden Business School of the University of Virginia and his B.A. from Rollins College.
Positions
- Company NameVerrica Pharmaceuticals Inc.Stock CodeVRCAPositionPresident, CEO & DirectorColleagues
- PBPaul B. ManningChairman of the Board
- JJJohn J. KirbyInterim Chief Financial Officer
- NLNoah L. RosenbergChief Medical Officer
- DZDavid ZawitzCOO, Chief Legal Officer & Secretary
- ESEugene ScavolaExecutive Vice President of Technical Operations
- MAMark A. PrygockiIndependent Director
- LFLawrence F. EichenfieldIndependent Director
- DNDiem NguyenIndependent Director
